MonarQ
Brief description of study
The study will be a prospective, multi-center, non-randomized trial with all subjects enrolling into a single arm receiving the inQB8 MonarQ TTVR system. Subjects suffering from severe or greater, symptomatic tricuspid regurgitation who are anatomically suitable for the MonarQ device and who have been determined to be intermediate or high risk for open-heart surgery by a Local Heart Team.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or